Coronavirus Vaccine: Who Will Be First To Get Vaccinated?

Coronavirus vaccine

Coronavirus affects the lives of millions across the globe. The impact of the virus on the individual life, social life, and financial condition of the individual is drastic. One thing is for sure is that life can only get to normal only if research institutions with scientists form a proper treatment for COVID-19.

The COVID-19 alters the global situation, global economy, tourism, and also the lives of nations. Treatment strategies for coronavirus include monoclonal antibodies therapy, vaccines, plasma therapy, and some medicines like aspirin. According to recent research about the virus, precautionary measures and guidelines alter. 

Moreover, the Center of Diseases Control and the U.S. Food and Drug Administration are controlling and monitoring the formulation process of treatments. Furthermore, the CDC and FDA are responsible for approving treatment strategies for emergency use or public use. 

ALSO READ: What to do Next – Boost Your Immune System To Fight COVID-19

Coronavirus Vaccine To Be Given To Whom

The federal advisory panel recommends on Tuesday to give the COVID-19 vaccine to an estimated 21 million health care workers. The panel also suggests giving the vaccine to 3 million residents and staff of nursing homes along with other long-term-care-facilities providers. 

The federal advisory panel suggests these people because they are at maximum exposure to the COVID-19. And also, these people play a vital role in keeping the nation safe. Furthermore, the healthcare workers, nursing home staff, and other care facilities providers play an essential part in running the clinics and hospitals and help in treating thousands of people. Thus, these people are at the highest priority of the panel.

Another reason for their selection is that 40% of deaths from COVID-19 occur in individuals who belong to these professions. So Robert Redfield, Director of the Centers for Disease Control and Prevention, approved the recommendation of the panel. Alex Azar is the Secretary of Health and Human Services.  Robert Redfield also informed Alex Azar about the approval of the panel-recommendation for the highest priority group.

Opposition view

By voting, the panel members finalized their recommendation priorities. Some of the members were against giving the COVID-19 vaccine to the health care workers right away as the safety and efficacy data is not sufficient to immunize such professional assets.

Helen Keipp Talbot is an associate professor of medicine at Vanderbilt University and was the sole dissenting vote. She highlights the probability that the vaccine may cause side-effects after a longer duration, which can jeopardize the safety of healthcare professionals. 

In addition, safety monitoring of those getting the shots in long-term-care settings is often inadequate. Talbot hopes that the vaccine works safely and effectively. However, other members were confident of vaccine usage and agreed to give priority to health care professionals.

ALSO READ: mRNA COVID-19 Vaccine – An Innovation In Vaccination 

Prioritizing Workers For The Next Round Of COVID-19 Vaccine

Beth Bell was chairing the panel, and she said that it’s a critical time, as on average, one COVID-19 death occurs in one minute. She emphasizes that the immunizing-panel is not acting soon because the situation is getting out of hand. 

On Tuesday, the United Food and Commercial Workers International Union of 1.3 million food and retailer workers urged the CDC to prioritize the workers in the next round of COVID-19-vaccine. The union emphasizes prioritizing workers from grocery stores, slaughtering houses and food processing. Because, thousands of these workers have already died due to infection from the virus.

Redfield, Deborah Birx, and Adam. Brett Giroir wants to prioritize older Americans. Coronavirus-vaccine of 40 million doses will be available to immunize 20 million Americans, of which 6.7 million will be receiving the vaccination first. The pressure over prioritizing will continue to increase as the days get closer to the FDA meeting, after which the FDA will likely give emergency use authorization. 

Adeena Tariq Lari
The author is a graduate of dental surgery from the Dow University Health Sciences, Karachi. She has an academic background in content writing as well as English literature, giving her an edge in the field. Adeena is always curious about physical and mental health. She is always passionate about research and delivering high-quality reliable content to users.